 Treatment fulminant hepatic failure insulin glucagon randomized controlled trial Insulin glucagon therapeutic modalities treatment fulminant hepatic failure FHF randomized trial insulin glucagon patients FHF viral toxin exposure control treatment groups patients etiology admission laboratory values Mortality different control treatment groups Time randomization death discharge different groups Peak levels alpha-fetoprotein survivors nonsurvivors error combination insulin glucagon useful treatment FHF